Biocare Lifesciences

What Biocare Lifesciences does

Biocare Lifesciences Inc is a Philippine-headquartered pharmaceutical importer and distributor founded in 2013 (per company history; the firmographics block lists 2012) by managing director and co-founder Dileep Tiwari alongside co-founder Kimberly Tiwari. The company imports, registers, distributes, and markets a portfolio of approximately 35 branded pharmaceutical products across therapeutic categories including Anti-Infectives, Respiratory and Immunology, Genito Urinary, Pediatric, Nephro, Pulmo, Anesthesia, Haematopoietic Agents, Neuromuscular agents, Anti-Fungals, Proton Pump Inhibitors, food supplements, vitamins and antianemics, and COVID-19 vaccines and therapeutics. Its flagship technical asset is Rabeloc IV, a US and UK patented Rabeprazole IV formulation that positions Biocare as a global innovator of this injectable proton-pump-inhibitor format.

The business model is a traditional specialty pharma distribution and detailing play. Biocare sources from a network of about 20 international manufacturing partners — including Cadila, Cipla, MSN, Hetero, Gland, EVA Pharma, and Korean manufacturers Dongkook, Seoul Pharma, and Daehwa — and resells the finished, regulatory-approved products into the Philippines. Revenue is generated through quote-based, multi-year contracts with healthcare professionals (doctors and pharmacists) reached by Territory Sales Managers, OTC pharmacy channels for supplements, and government institutions for COVID-19 vaccine supply.

Go-to-market is sales-led and event-driven. The company deploys a direct field-sales force that conducts product training and detailing in Manila and assigned territories, reinforced by participation in major Philippine medical conventions (Philippine College of Surgeons, Asian Pacific Association for the Study of the Liver, Philippine College of Chest Physicians, Philippine Society of Digestive Endoscopy, and the Philippine Society of Anesthesiologists). The company claims a 10-country footprint, PIC/s/EU/USFDA-grade regulatory compliance on its portfolio, a 2020-21 Best Choice award, and a workforce of approximately 100 employees operating out of Makati City. Biocare is privately held, bootstrapped, with no disclosed external funding rounds or institutional investors.

Name

Biocare Lifesciences

Legal name

Biocare Lifesciences Inc

Website

https://biocarelifesciences.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Biocare Lifesciences Inc is a Philippine-headquartered pharmaceutical distributor that imports, registers, and markets approximately 35 branded specialty products across anti-infectives, respiratory, gastroenterology, anesthesia, and COVID-19 therapeutics to Filipino doctors, pharmacists, and government institutions via a Territory Sales Manager field force.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

akta.pro secondary industries

Biologics & Biosimilars Distributors (HLAIAJAH), Probiotics & Digestive Health Supplements (CRADAGAF), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Pharmaceutical distribution
• Prescription medications
• Over-the-counter medicines
• Covid-19 vaccines
• Food supplements

Headquarters

HQ city

Makati

HQ country

Philippines

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Distribution: Biocare Lifesciences generates revenue through distribution and marketing of pharmaceutical products including prescription drugs, OTC medications, and Covid-19 vaccines across the Philippines. They import, register, and distribute products from manufacturing partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Biocare Lifesciences Inc is a Philippine-based pharmaceutical distributor engaged in the importation, registration, distribution, and marketing of pharmaceutical products across the Philippines. The company offers a portfolio of approximately 35 prescription drugs, over-the-counter (OTC) medicines, food supplements, and Covid-19 vaccines spanning therapeutic categories including Anti-Infectives, Respiratory & Immunology, Genito Urinary, Vitamins & Antianemics, Muscle Relaxants, Analgesics, Haematopoietic Agents, Neuromuscular Agents, Anti-Fungals, and Proton Pump Inhibitors. Products are sourced from 20 manufacturing partners including Cadila, Cipla, MSN, Hetero, and others.

Product overview

Biocare Lifesciences Inc is a Philippine-based pharmaceutical distributor engaged in the importation, registration, distribution, and marketing of pharmaceutical products across the Philippines. The company offers a portfolio of prescription drugs, over-the-counter (OTC) medicines, and COVID-19 vaccines. Product categories include Anti-Infectives (such as AMERO, FLOXSAFE IV, CEFSUL IV), Respiratory & Immunology (SALFLUSOL MDI, HICAIRE), Genito Urinary (AMSO, ANEXXX), Food Supplements (BACIFLORA, ALIVER, AK LOG), Vitamins & Antianemics (REFERIS), Muscle-Relaxants (REPOSE), Analgesic Antipyretic (PARAM), Haematopoietic Agents (Pronivel-IV), Neuromuscular Agents (NEOSTIGMINE METHYLSULFATE), Anti-Fungals (FUNGIV), and Proton Pump Inhibitors (RABELOC I.V.). The company also distributes COVID-19 related products including Remivir (Remdesivir). Products are sourced from manufacturing partners including Cadila, Cipla, MSN, Hetero, Gland, Medisol, EVAPHARMA, Dongkook, Seoul Pharma, and Daehwa.

Differentiator

Problem solved

Functional benefit

Products and services

• AMERO Anti-infective medication for treating bacterial infections, distributed across the Philippines.
• SUNCETIN Anti-infective medication distributed by Biocare Lifesciences in the Philippines.
• FLOXSAFE IV Film-coated tablet antibacterial medication for bacterial infections.
• CEFSUL IV Intravenous anti-infective medication distributed by Biocare Lifesciences.
• PODOXI Anti-infective medication distributed by Biocare Lifesciences in the Philippines.
• PROPITAZ IV Intravenous anti-infective medication distributed by Biocare Lifesciences.
• ORSA Anti-infective medication distributed by Biocare Lifesciences in the Philippines.
• ELORES Anti-infective medication distributed by Biocare Lifesciences.
• SALFLUSOL MDI Respiratory medication delivered via metered-dose inhaler for asthma and related conditions.
• HICAIRE Respiratory and immunology medication distributed by Biocare Lifesciences.
• AMSO Genito urinary medication distributed by Biocare Lifesciences in the Philippines.
• ANEXXX Genito urinary medication distributed by Biocare Lifesciences in the Philippines.
• AK LOG Dietary food supplement distributed by Biocare Lifesciences.
• ALIVER Dietary food supplement distributed by Biocare Lifesciences.
• BACIFLORA Probiotic dietary food supplement in liquid form distributed by Biocare Lifesciences.
• REFERIS Vitamin and anti-anemic medication distributed by Biocare Lifesciences.
• REPOSE Muscle relaxant medication distributed by Biocare Lifesciences.
• PARAM Paracetamol 10 mg/mL (1 g/100 mL) solution for IV infusion for pain control and fever reduction.
• Pronivel-IV Epoetin Alfa solution for injection (IV/SC) for treatment of symptomatic anemia associated with chronic renal failure.
• NEOSTIGMINE METHYLSULFATE Anticholinesterase agent (500 mcg/mL solution for injection) for reversal of neuromuscular blocking agents, myasthenia gravis, and other indications.
• FUNGIV Fluconazole 2 mg/mL I.V. solution for fungal infections.
• RABELOC I.V. Rabeprazole Sodium 20 mg powder for solution for injection and 20 mg enteric coated tablet — US and UK patented Rabeprazole IV for gastric acid suppression, with faster impact on gastric pH, more potent than other PPIs, and a safer profile.
• Maxzith 500 Azithromycin 500 mg film-coated tablet prescription antibiotic distributed by Biocare Lifesciences.
• Remivir Remdesivir 100 mg lyophilized powder for injection for COVID-19 treatment, supplied under Biocare Lifesciences' authorized Covid-19 vaccine supplier status in the Philippines.

Quantifiable outcome

• 10+ years of successful operation in Philippines
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered major, core and minor.

• CadilamajorChannel Partner/ Reseller/ DistributorManufacturing and supply partnership for pharmaceutical products including Rabeloc IV (Rabeprazole). Cadila is a major Indian pharmaceutical company.
• CiplamajorChannel Partner/ Reseller/ DistributorManufacturing partnership for pharmaceutical products. Cipla is a major global pharmaceutical company.
• MSNcoreChannel Partner/ Reseller/ DistributorManufacturing partner for pharmaceutical products.
• HeterocoreChannel Partner/ Reseller/ DistributorManufacturing partnership for pharmaceutical products including generic medications.
• GlandminorChannel Partner/ Reseller/ DistributorManufacturing partner for pharmaceutical products.
• MedisolminorChannel Partner/ Reseller/ DistributorManufacturing partner for pharmaceutical products.
• EVAPHARMAminorChannel Partner/ Reseller/ DistributorManufacturing partnership for pharmaceutical products.
• DongkookminorChannel Partner/ Reseller/ DistributorManufacturing partner for pharmaceutical products from Korea.
• Seoul PharmaminorChannel Partner/ Reseller/ DistributorManufacturing partner for pharmaceutical products from Korea.
• DaehwaminorChannel Partner/ Reseller/ DistributorManufacturing partner for pharmaceutical products from Korea.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hizon Laboratories: Philippine pharmaceutical contract manufacturer and distributor of generics, OTC, and supplements with a portfolio and distribution model that closely mirrors Biocare's importer-distributor approach in the same market.
• Pascual Laboratories: Philippine pharmaceutical company that both manufactures and distributes branded generics, OTC, and food supplements, overlapping with Biocare across therapeutic categories, OTC, and supplement distribution in the Philippines.
• Metro Drug Inc: One of the largest Philippine pharmaceutical distribution and marketing companies, importing and distributing branded and generic medicines to retail pharmacies and hospitals across the same customer base Biocare serves.
• GX International Philippines: Philippine importer and distributor of pharmaceutical and consumer health products from international manufacturers, operating a comparable principal-partner marketing and distribution model in the same territory.
• Doctor's Pharmaceutical (Doctor's Pharma): Philippine pharmaceutical distribution and marketing company focused on branded generics and specialty products marketed through medical representatives to physicians and pharmacies, closely matching Biocare's sales-led GTM and product categories.
• Pharmaforte Philippines: Philippine pharmaceutical marketing and distribution company that imports and distributes specialty and branded generic products from international principals, paralleling Biocare's principal-partner model.

Broad incumbents

• Zuellig Pharma: Asia's largest pharmaceutical distributor with deep Philippines operations and a multi-country, multi-therapeutic distribution footprint that directly overlaps Biocare's distribution, importation, and marketing model in the same market.
• United Laboratories (Unilab): Philippines' largest domestic pharmaceutical manufacturer and distributor, with a branded generics portfolio that competes head-to-head with Biocare's distributed generics and OTC products across the same pharmacy and hospital channels.
• DKSH Philippines: Swiss-based market expansion services group with a major healthcare distribution business in the Philippines providing importation, registration, sales, and distribution services for pharmaceutical principals — directly comparable to Biocare's outsourced distribution model.

Regional players

• CCBPI (Cosmic/Coca-Cola bottler pharma arm) / AdvaCare Pharma: Asia-focused pharmaceutical manufacturer and distributor offering generics, OTC, and supplements across multiple therapeutic categories through partner-distributor networks, providing a regional comparable to Biocare's manufacturer-partner channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/BiocareI
• Facebookfacebook.com/BiocareLifesciencesInc
• LinkedInlinkedin.com/company/biocare-lifesciences-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biocare Lifesciences